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Abstract
Background: Building on previous acceptability research undertaken in sub-Saharan Africa this article aims to
investigate the acceptability of intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea
(PNG).
Methods: A questionnaire was administered to mothers whose infants participated in the randomised placebo
controlled trial of IPTi. Mothers whose infants participated and who refused to participate in the trial, health
workers, community reporters and opinion leaders were interviewed. Men and women from the local community
also participated in focus group discussions.
Results: Respondents viewed IPTi as acceptable in light of wider concern for infant health and the advantages of
trial participation. Mothers reported complying with at-home administration of IPTi due to perceived benefits of
IPTi and pressure from health workers. In spite of patchy knowledge, respondents also demonstrated a demand for
infant vaccinations and considered non-vaccination to be neglect. There is little evidence that IPTi has negative
impacts on attitudes to EPI, EPI adherence or existing malaria prevention practices.
Conclusion: The degree of similarity between findings from the acceptability studies undertaken in sub-Saharan
Africa and PNG allows some generalization relating to the implementation of IPTi outside of Africa: IPTi fits well
with local health cultures, appears to be accepted easily and has little impact on attitudes towards EPI or malaria
prevention. The study adds to the evidence indicating that IPTi could be rolled out in a range of social and cultural
contexts.
Background
Intermittent preventive treatment (IPT) of malaria
involves the administration of treatment doses of an
anti-malarial drug at predetermined intervals, regardless
of parasitaemia or symptoms. IPT during pregnancy
(IPTp) is linked to ongoing routine antenatal care and
IPT for infants (IPTi) is delivered through the Expanded
Programme of Immunization (EPI) [1].
Various studies in sub-Saharan Africa have shown that
IPTi with sulphadoxine-pyrimethamine (SP) given at the
time of routine vaccinations in the first year of life
reduces the incidence of clinical malaria by between
20% and 59% [2-7], and by 30% across the six sites [8].
In addition to the clinical effectiveness of IPTi, recent
social science research has also demonstrated that in
several sites across sub-Saharan Africa, IPTi is socially
and culturally acceptable [9-11]. This acceptability
research, undertaken alongside clinical trials (in Gabon,
Kenya, Mozambique and Tanzania) and implementation
studies of IPTi (in Ghana, Malawi and Tanzania) with
various drug regimens, also indicated that IPTi does not
negatively influence attitudes to and uptake of immuni-
zation, nor is IPTi misunderstood as immunization
against malaria. IPTi does not, therefore, influence other
preventive measures or delay treatment seeking for
malaria.
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Although the acceptability research published to date
provides a comprehensive insight into community
responses to IPTi delivered in sub-Saharan Africa, there
are no published data on the acceptability of IPTi out-
side of sub-Saharan Africa. Given that IPTi has the
potential to reduce the malaria-related morbidity and
mortality for infants in other regions with a significant
level of malaria mixed endemicity (Plasmodium falci-
parum and Plasmodium vivax), such as South-East Asia
or Oceania, it is crucial to ensure that IPTi is socially
and culturally acceptable in distinct social and cultural
settings outside of sub-Saharan Africa.
Building on previous acceptability research undertaken
in sub-Saharan Africa and in the context of an IPTi trial
in Papua New Guinea (PNG), this article aims to:
1. Describe knowledge, perceptions, experiences and
responses relating to IPTi and EPI of trial participants,
community members, and local health care providers
2. Identify and understand the mutual interactions
between perceptions of, attitudes to and experiences
with EPI and IPTi.
3. Identify and understand local barriers to the accep-
tance of and long-term adherence to IPTi.
4. Identify wider socio-cultural, national and regional
factors that affect, or may affect, the implementation or
acceptability of IPTi.
Setting
The acceptability research undertaken in PNG was carried
out alongside a randomized placebo-controlled clinical
trial of IPTi, which was run by the Papua New Guinea
Institute of Medical Research (IMR) and carried out under
the auspices of the IPTi Consortium with the financial
support of the Bill and Melinda Gates Foundation. The
trial tested the following drug regimens: single dose of SP
associated to three days of either amodiaquine or artesu-
nate given four times at three, six, nine and 12 months
following the PNG EPI schedule. Each dose of the three-
dose regimen was given on consecutive days: trial staff
gave the first dose; the second and third doses were given
to mothers to administer to their infants the following
days. The study drugs were administered in collaboration
with local health facilities responsible for operating
Mother and Child Health (MCH) clinics, which, due to
the scattered nature of settlements in PNG, deliver EPI
through monthly village outreach services.
Although the trial commenced in two areas of PNG,
East Sepik Province and Madang Province, in 2008, the
East Sepik site was closed due to a lower than excepted
malaria incidence. The acceptability research therefore
focused upon Madang Province, a mainly coastal low-
land (0-500 m) with a high year-round malaria transmis-
sion rate. The study was carried out about 60 km north
of Madang town.
PNG is renowned for its linguistic and cultural diver-
sity, and in the study area six languages coexist. However,
this contrasts with the lack of socio-economic differentia-
tion in rural areas. In Madang province, subsistence
farming of a range of crops (including sweet potatoes,
greens and tropical fruits) is the main livelihood activity.
In addition, both men and women migrate to Mandang
town, which is one of the few urban centres in PNG.
Methods
The methods employed in this study were based on
those used in the acceptability studies carried out in
sub-Saharan Africa [9-11]. In PNG, emphasis was placed
on a questionnaire survey of mothers whose infants par-
ticipated in the IPTi trial. Additional individual in-depth
interviews and focus group discussions with mothers,
health workers, village reporters (community members
employed by the IPTi trial recording study drug adher-
ence and the occurrence of adverse events), opinion lea-
ders and community members were also undertaken in
order to triangulate findings from the questionnaires.
The topics explored in the data collection tools were
drawn from previous studies and modified to suit the
context. These topics included, amongst others: knowl-
edge, understanding and attitudes regarding vaccination;
vaccination behaviour; experiences of vaccination; and,
knowledge and understanding of IPTi. The behaviour of
health workers and participant mothers was also
observed during delivery of IPTi and field notes taken.
Respondents were drawn from four villages within the
IPTi trial recruitment area. Initial sampling was based on
convenience, e.g. mothers who were willing to be inter-
viewed were recruited through study clinics. As the study
developed theoretical sampling was used: participants
were recruited on the basis of the research team’s devel-
oping understanding of the field and the questions that
emerged from the ongoing analysis of already collected
data. The numbers of questionnaires, interviews and
FGDs (see Table 1), were determined by the point of
saturation (when no more novel information emerged).
Prior to their participation, informed consent was
obtained from all study respondents in accordance with
Table 1 Study respondents and data collection tools
Type of respondent Data collection toola N
Participant mothers IDI 23
QNN 213
Mother refusers IDI 2
Health workers IDI 5
Village reporters IDI 2
Opinion leaders IDI 2
Community members FGD 6
aIDI: in-depth interview; QNN: questionnaire; FGD: focus group discussion.
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local ethics committee regulations. Interviews were car-
ried in Tok Pisin (formerly, Pidgin English) or English,
and with the agreement of respondents, recorded and
transcribed verbatim, and, when necessary, translated
into English by field workers for analysis.
Qualitative data analysis was carried out employing a
Grounded Theory approach [12], with more abstract
generalizations emerging from the data based on the
coding of emerging themes using QSR Nvivo 2. Descrip-
tive statistics from the qualitative data were generated
using SPSS 14.0.
Overall ethics clearance for the acceptability research
was obtained from the Ethics Committee of the Comité
Ético de Investigación Clínica of the University of Barce-
lona. Separate local ethical clearance was obtained from
the PNG Medical Research Advisory Committee and the
PNG Institute of Medical Research Institutional Review
Board (IRB), approval number 0807.
Results
Acceptability and adherence
A number of key factors have emerged from the data
that influence the acceptability of IPTi in positive or
negative ways. These factors relate to local attitudes
towards infant care and vaccinations, the clinic environ-
ment, the IPTi regimen and the nature of the clinical
trial context.
Local health culture and the routinization of EPI
The interviews with mothers whose infants participated
in the study indicate that there is common awareness of
and demand for EPI vaccinations. Although the mothers
were unable to name all the diseases that vaccination pre-
vents (56% [119/213] could name some), they knew that
vaccination prevented diseases or provided protection
(91% [194/213]), were positive towards vaccination and
often distressed by the possibility that their children may
miss out on vaccination. Although over 20% (47/213) of
mothers stated that vaccination provides prevention
against malaria, it is unclear to what extent this was due
to confusion with the IPTi study. Vaccinated children
were viewed as healthy; indeed keeping the child healthy
was cited as the reason for vaccinating children by over
40% of mothers (87/213). There was debate about
whether vaccination provided complete or partial preven-
tion for diseases, with general opinion leaning towards
partial prevention: vaccination gave some protection, but
complete prevention depends on other factors; the dis-
ease would develop more slowly giving mothers chance
to go to the clinic; or, the child could be sick again in the
future.
Reports of vaccination-related side effects were mini-
mal (2% [5/213] of participant mothers reported side
effects), and descriptions focused on mild fever or pas-
sing distress. Although relatives and neighbours were
said to complain occasionally of children crying after
vaccination, mothers were able to dismiss these com-
plains and they did not prevent them from vaccinating
their children. Children receiving multiple injections
during a single clinic visit was said to cause concern
amongst mothers and relatives. Sometimes relatives
questioned mothers about the number of injections that
the child had received and said that two was too many.
One mother reported getting angry after seeing blood
drip down her child’s arm after vaccination.
In spite of the concerns about multiple injections, very
few mothers reported factors preventing them from vac-
cinating their children (one reported that if she was too
busy she may be unable to take her children, another
that her husband could prevent her, one mentioned
transport problems and one described how she would
not be able to go if she was sick). However, in the quali-
tative interviews, other factors mentioned included:
health workers reprimanding mothers for missing pre-
vious appointments; difficulties in meeting the costs
levied at the clinic; and, laziness.
Although the data suggest that mothers are responsi-
ble for the healthcare of the children, taking them to
the clinic and caring for them in the home, fathers often
play the role of ultimate decision-maker, to whom
women have to seek permission to travel to the clinic.
Fathers also take a more prominent role in emergencies.
Whilst respondents did not report that husbands pre-
vented them from vaccinating their children, there were
scattered reports, offered by mothers, of other women’s
husbands preventing their wives from participating in
the IPTi trial. However, one health worker suggested
that this might be an easy excuse to avoid refusing
directly. The women who participated in the trial
reported having made the decision to participate with
their husbands, who agreed because they saw the
benefits.
The data revealed only scattered accounts of the use
of non-biomedical means of preventing disease: two
mothers reported using “paw paw” seeds to prevent dis-
ease, and one mother specifically mentioned preventing
malaria; one mother referred to herbs more generally;
and, a health worker described the use of amulets for
spiritual protection by members of the local Catholic
church. Herbal remedies were more popular for curing
rather than preventing: respondents described a range of
remedies for mild diseases such as cough, cold, diar-
rhoea and fever. Mothers, however, preferred that ser-
ious diseases be dealt with in the clinic.
IPTi drugs, adherence and reasons for refusal
Two-thirds of mothers interviewed knew that the IPTi
trial involved malaria prevention (67% [143/213]) and
almost three-quarters knew they were participating in
research (74% [157/213]). However, the vast majority
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(87% [186/213]) were unsure about the names of the
drugs used, and only four named Fansidar (the brand
name for SP) as one of the study drugs. Nevertheless,
the mothers were almost universally content with their
experiences of the trial: the IPTi drugs, the outreach
clinics and the free treatment. Mothers reported a
decrease in malaria amongst the participating infants
and commented more generally on the health of the
infants, comparing it favourably with that of other chil-
dren who did not participate. They also reported that
study participation had brought broader benefits as they
travelled less often to the clinic and had more time to
do other activities such as work. Indeed, mothers com-
monly enrolled more that one of their children in the
study. Trial staff were considered diligent and caring,
compared to other health staff who were rude, slow to
deal with mothers, and did not give proper care. One
mother conceded that this might be due to the health
workers’ heavy workload. A common concern expressed
by respondents was what would happen when the IPTi
trial came to an end in the area.
Reports of side effects from the IPTi drugs were also
rare: two mothers referred to the child’s body being
weak, but that they quickly recovered; a third, described
how her child was seen by one of the trial doctors after
suffering a reaction to the trial drugs. In none of the
cases was the mother discouraged from continuing her
participation.
IPTi was delivered in three doses at four intervals to
infants who participated. Two doses were left with the
mother to give to the child the following days. Fifteen
percent of mothers (31/213) reported that they some-
times did not give the IPTi drug as instructed. The
majority, who reported having followed the instructions,
did so out of the belief that the drugs would help the
child and not doing so would be akin to neglect or due
to pressure from health workers.
Respondents reported that during the trial and parti-
cularly the recruitment phase there were reports that
blood sampled from participants was being sold by the
local research institute. People with less experience of
research, such as men, the elderly and the residents of
remote villages, were said to spread these rumours.
Indeed, the majority of participant mothers surveyed
reported that the blood was used for diagnostic pur-
poses (62% [133/213] referred specifically to testing for
malaria). One woman, who refused to participate in the
IPTi trial, did so because she believed that the blood
would be used for transfusion, something that she dis-
agreed with. Although there were concerns from two
participants about their children losing blood and 16%
(33/213) of mothers were unsure about the purpose of
the blood sampling, many mothers paid little attention
to these complains. The majority of the mothers who
refused to participate or dropped out from the study did
so because of the rumours associated with blood sam-
pling and not because of IPTi per se.
The influence of IPTi on disease prevention
There is no evidence that IPTi had a negative impact
upon EPI adherence. Given the support that the staff
employed by the clinical trial gave to the local health-
care system, in the local clinics and at monthly outreach
visits to the communities, it is likely that EPI adherence
increased during the trial. Furthermore, all participant
mothers were positive about their participation.
Participant mothers perceived IPTi as offering complete
prevention from malaria: 98% (208/213) of mothers stated
that after IPTi their children would not get malaria. This
finding is however contradicted by the extent of bed net
usage: over three-quarters (77% [163/213]) of participant
mothers reported using bed nets as a means of malaria
prevention. There was however debate about the effective-
ness of bed nets. The new bed nets that were being
handed out to trial participants were considered effective
at repelling the mosquitoes, in contrast to the less useful
older nets. One health worker attributed the popularity of
bed nets, to previous campaigns of mosquito eradication
that had left a strong message about the importance of
preventing mosquito bites.
Discussion
In a similar fashion to acceptability studies undertaken in
Africa [9], the data from PNG indicate a general concern
about infant health and that mothers were generally
motivated to comply with prevention practices, regard-
less of whether they fully understood them or not.
Although mothers who participated in the IPTi trial were
often not entirely clear about the diseases that vaccina-
tions prevented, they viewed EPI non-compliance as
neglect. This was based on the general distinction that
they drew between the health of un-vaccinated and vacci-
nated children. Although references to traditional pre-
vention practices were very rare in the PNG data
(a finding which differentiates PNG from other sub-
Saharan African sites [9-11]) the observed benefits of
vaccination, together with the general concern about
infant health, formed a favourable context for the accep-
tance and routinization of both EPI and IPTi.
The presence of the IPTi trial in PNG did not nega-
tively affect participants’ attitudes towards EPI vaccina-
tions, nor did it influence their other malaria prevention
practices, as was the case in the sub-Saharan African
sites [9-11]. However, whilst in the sub-Saharan African
sites, the preventive healthcare practices, including IPTi,
were almost always considered as bestowing only partial
protection, in PNG mothers viewed IPTi as providing
complete protection from malaria. Although one may
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expect a decrease in bed net usage to accompany this
finding, no such reduction was reported. This may be
the result of the general compliance with preventive
practices or to avoid nuisance mosquito bites. However,
if IPTi were implemented across PNG and delivered as
part of EPI further research on bed net usage would be
useful to confirm this finding.
One of the main determinants of acceptability is
whether recipients and other community members per-
ceive the intervention as performing as they think it is
supposed to, and whether the benefits are perceived to
outweigh the disadvantages. In the case of the clinical
trial of IPTi in PNG, participant mothers understood
that IPTi was intended to prevent malaria in infants and
they identified a positive effect upon the health of parti-
cipating infants and perceived a decrease in malaria inci-
dence. In a similar fashion to the clinical trial sites,
where acceptability studies have been undertaken
(Kenya, north-eastern Tanzania, Mozambique and
Gabon [9-11]) participant mothers and other commu-
nity members viewed the benefits of trial participation,
which included the free high-quality health care pro-
vided by the trial staff at local clinics and during out-
reach services, and the perceived reduction in malaria
amongst participating infants as outweighing any con-
cerns about the blood sampling and associated rumours
of “blood selling”.
Because, in clinical trial settings, it is difficult to iso-
late the advantages and disadvantages linked to trial
from those linked to the intervention, it is challenging
to distinguish what precisely motivates mothers to
attend clinic and adhere to treatment, and this makes it
difficult to assess how they would respond in a more
routine implementation setting. However, given the
similarities with the response in the intervention sites in
Africa it seems likely that the response in “natural” set-
tings will not be very different. In the intervention stu-
dies with SP in Malawi and Ghana, ‘IPTi was simply an
unnoticed addition to an already routinized EPI’ [9].
During the PNG trial of IPTi participants had greater
opportunity for non-adherence than in the other clinical
trials of IPTi: mothers were given the two last doses of
the trial drug to administer themselves at home.
Although perhaps inflated by desirability bias, the major-
ity of mothers reported having always given the doses as
instructed, motivated by the benefits they perceived that
the previous doses had proportioned their child (or chil-
dren). Although a single dose drug regimen for IPTi
would be ideal, in order to avoid potential non-
adherence, the results from this study suggest that if they
perceive benefits, mothers are prepared to administer
drugs for prevention unsupervised. Data from other
acceptability studies, where health workers sometimes
provided IPTi drugs for mothers to administer at home,
despite being instructed not to, suggest that some
mothers did give the drugs correctly. Other mothers for-
got and some, given that they thought the drug was to
cool the post-vaccination fever, only gave if the child had
fever [9,11]. The latter indicates the importance of pro-
viding, in addition to the medication, clear, relevant
information.
Respondents’ concerns about the care that their
infants would receive when the trial ends highlight the
broader issue of the feasibility of implementing IPTi in
PNG and in other countries with resource-poor health
systems. Research in sub-Saharan Africa has, however,
shown IPTi to be a cost-effective intervention [13] and
pilot implementation studies undertaken by UNICEF in
six African countries indicated that IPTi with SP was a
feasible intervention, reaching 97% of immunized infants
[14]. In spite of these, findings, efforts are required to
address the poor coverage and timeliness of childhood
immunization outside of the urban centres in PNG [15].
Furthermore, in a third of cases reported in this study,
non-vaccination was attributed to problems with the
health services [15], which illustrates the need for
investment in the provision of MCH outreach services.
Although, the data presented provide some insight into
health workers’ behaviour towards mothers attending
MCH for immunization and its effect on immunization
adherence, this requires further in-depth study.
The data collected in PNG illustrate additional, strik-
ing similarities to those from acceptability studies
undertaken in sub-Saharan Africa. For example, mothers
in all sites were familiar with vaccination as prevention
yet uncertain regarding particular diseases prevented
and the nature of the prevention. Also the key barriers
to attending clinics, mainly distance and transport and
treatment costs, were common in sub-Saharan Africa
and PNG. There were also common complaints about
(non-trial) health staff that criticize and chastise
mothers in the clinic [16]. The data also suggest that
the role of fathers in infant care is similar: although
fathers play a relatively minor role in day-to-day child-
care, when more serious matters arise, such as participa-
tion in a clinical trial or severe illness, they take the role
of decision-makers. Even the nature of the rumours that
circulated around the clinical trial of IPTi in PNG, relat-
ing to the selling of the blood sampled, resonated
strongly with the rumours encountered in other trial
sites [9,10].
Strengths and limitations of the study
A clinical trial is not the ideal context to investigate the
acceptability of any intervention as many of the factors
that affect a community’s response to the intervention
itself are influenced by the presence of the trial. How-
ever, in the case of IPTi in PNG, it was the only way of
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collecting acceptability data early enough to be able to
make recommendations for improving access and long-
term adherence during roll out. Using a range of meth-
ods (including direct observation of behaviour) and
interviewing a range of respondents, enabled the trian-
gulation of findings and ensured their reliability.
Conclusions
The findings presented complement a broader
programme of social science research undertaken in
sub-Saharan Africa [9]. The inclusion of PNG as an
additional site for acceptability research enables compar-
isons to be made between this very different social and
cultural context and the sites in sub-Saharan Africa.
The results of the acceptability research in PNG are
remarkably similar to those from the African sites and
this allows tentative generalization regarding IPTi imple-
mentation beyond Africa. Firstly, IPTi seemingly fits well
with local health cultures and appears to be accepted
easily. Secondly, there is little evidence that IPTi has
negative impacts on attitudes to EPI or EPI adherence.
Furthermore, although in PNG mothers described IPTi
as complete malaria prevention this did not, as in other
African sites, influence existing malaria prevention and
treatment-seeking behaviour. In practical terms, the
degree of similarity across the sites suggests that IPTi
would require minimal adjustment in order to be rolled
out successfully across diverse social and cultural con-
texts. The generalizability of findings vindicates the
overall research approach of undertaking small-scale
social science studies in many sites.
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